These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23963720)

  • 1. Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity.
    Cellai AP; Lami D; Antonucci E; Liotta AA; Rogolino A; Fedi S; Fiorillo C; Becatti M; Cenci C; Marcucci R; Abbate R; Prisco D
    J Thromb Thrombolysis; 2014 Jul; 38(1):45-9. PubMed ID: 23963720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism.
    Stępień K; Ząbczyk M; Kopytek M; Natorska J; Zalewski J; Undas A
    J Thromb Thrombolysis; 2024 Feb; 57(2):248-259. PubMed ID: 37932588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis.
    Zheng Z; Mukhametova L; Boffa MB; Moore EE; Wolberg AS; Urano T; Kim PY
    J Thromb Haemost; 2023 Apr; 21(4):1043-1054. PubMed ID: 36759279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation.
    Ząbczyk M; Natorska J; Janion-Sadowska A; Malinowski KP; Janion M; Undas A
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32235490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.
    Konstantinides SV; Vicaut E; Danays T; Becattini C; Bertoletti L; Beyer-Westendorf J; Bouvaist H; Couturaud F; Dellas C; Duerschmied D; Empen K; Ferrari E; Galiè N; Jiménez D; Kostrubiec M; Kozak M; Kupatt C; Lang IM; Lankeit M; Meneveau N; Palazzini M; Pruszczyk P; Rugolotto M; Salvi A; Sanchez O; Schellong S; Sobkowicz B; Meyer G
    J Am Coll Cardiol; 2017 Mar; 69(12):1536-1544. PubMed ID: 28335835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Kim NH; D'Armini AM; Grimminger F; Grünig E; Hoeper MM; Jansa P; Mayer E; Neurohr C; Simonneau G; Torbicki A; Wang C; Fritsch A; Davie N; Ghofrani HA
    Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
    Halank M; Hoeper MM; Ghofrani HA; Meyer FJ; Stähler G; Behr J; Ewert R; Fletcher M; Colorado P; Nikkho S; Grimminger F
    Respir Med; 2017 Jul; 128():50-56. PubMed ID: 28610669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
    Piazza G; Hohlfelder B; Jaff MR; Ouriel K; Engelhardt TC; Sterling KM; Jones NJ; Gurley JC; Bhatheja R; Kennedy RJ; Goswami N; Natarajan K; Rundback J; Sadiq IR; Liu SK; Bhalla N; Raja ML; Weinstock BS; Cynamon J; Elmasri FF; Garcia MJ; Kumar M; Ayerdi J; Soukas P; Kuo W; Liu PY; Goldhaber SZ;
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1382-1392. PubMed ID: 26315743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Final DENALI Trial Data: A Prospective, Multicenter Study of the Denali Inferior Vena Cava Filter.
    Stavropoulos SW; Chen JX; Sing RF; Elmasri F; Silver MJ; Powell A; Lynch FC; Abdel Aal AK; Lansky A; Muhs BE;
    J Vasc Interv Radiol; 2016 Oct; 27(10):1531-1538.e1. PubMed ID: 27569678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis for patients with intermediate-risk pulmonary embolism.
    Meyer G; Vicaut E; Danays T; Agnelli G; Becattini C; Beyer-Westendorf J; Bluhmki E; Bouvaist H; Brenner B; Couturaud F; Dellas C; Empen K; Franca A; Galiè N; Geibel A; Goldhaber SZ; Jimenez D; Kozak M; Kupatt C; Kucher N; Lang IM; Lankeit M; Meneveau N; Pacouret G; Palazzini M; Petris A; Pruszczyk P; Rugolotto M; Salvi A; Schellong S; Sebbane M; Sobkowicz B; Stefanovic BS; Thiele H; Torbicki A; Verschuren F; Konstantinides SV;
    N Engl J Med; 2014 Apr; 370(15):1402-11. PubMed ID: 24716681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients.
    Tapson VF; Hazelton JP; Myers J; Robertson C; Gilani R; Dunn JA; Bukur M; Croce MA; Peick A; West S; Lottenberg L; Doucet J; Miller PR; Crookes B; Gandhi RR; Croft CA; Manasia A; Hoey BA; Lieberman H; Guillamondegui OD; Novack V; Piazza G; Goldhaber SZ
    J Vasc Interv Radiol; 2017 Sep; 28(9):1248-1254. PubMed ID: 28642012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Balloon Pulmonary Angioplasty on Oxygenation in Patients With Chronic Thromboembolic Pulmonary Hypertension　- Importance of Intrapulmonary Shunt.
    Aoki T; Sugimura K; Nochioka K; Miura M; Tatebe S; Yamamoto S; Yaoita N; Suzuki H; Sato H; Kozu K; Miyata S; Satoh K; Shimokawa H
    Circ J; 2016 Sep; 80(10):2227-34. PubMed ID: 27581344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation-Fibrinolysis System and Postoperative Outcomes of Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Kato F; Tanabe N; Ishida K; Suda R; Sekine A; Nishimura R; Jujo T; Sugiura T; Sakao S; Tatsumi K
    Circ J; 2016; 80(4):970-9. PubMed ID: 26888150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
    van Es N; Di Nisio M; Bleker SM; Segers A; Mercuri MF; Schwocho L; Kakkar A; Weitz JI; Beyer-Westendorf J; Boda Z; Carrier M; Chlumsky J; Décousus H; Garcia D; Gibbs H; Kamphuisen PW; Monreal M; Ockelford P; Pabinger I; Verhamme P; Grosso MA; Büller HR; Raskob GE
    Thromb Haemost; 2015 Nov; 114(6):1268-76. PubMed ID: 26271200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.
    Kooiman J; den Exter PL; Kilicsoy I; Cannegieter SC; Eikenboom J; Huisman MV; Klok FA; Versteeg HH
    J Thromb Thrombolysis; 2015 Oct; 40(3):323-30. PubMed ID: 25665657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.
    Stewart LK; Peitz GW; Nordenholz KE; Courtney DM; Kabrhel C; Jones AE; Rondina MT; Diercks DB; Klinger JR; Kline JA
    J Thromb Thrombolysis; 2015 Aug; 40(2):161-6. PubMed ID: 25433511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 and thrombosis.
    Bettiol A; Urban ML; Emmi G; Galora S; Argento FR; Fini E; Borghi S; Bagni G; Mattioli I; Prisco D; Fiorillo C; Becatti M
    Front Mol Biosci; 2023; 10():1325002. PubMed ID: 38304233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 19-Year-Old Man with a History of Recreational Inhalation of Nitrous Oxide with Severe Peripheral Neuropathy and Central Pulmonary Embolism.
    Pedersen OB; Hvas AM; Grove EL
    Am J Case Rep; 2021 Aug; 22():e931936. PubMed ID: 34376630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.